Published in Healthcare Mergers, Acquisitions and Ventures Week, February 3rd, 2007
Diluted earnings per share from continuing operations increased 13% to $2.32 for the 12-month period ended September 30, 2006 compared to $2.06 for the 12-month period ended September 30, 2005.
Included in the 12-month results were $1,488,000 of costs for stock option compensation, now required to be expensed, effective for all reporting periods beginning October 1, 2005, under Financial Accounting Standard No. 123(R).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.